# US 2012/0058521 A1 · Enzymatic oligonucleotide pre-adenylation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0058521 A1
- Document ID: US20120058521A1
- Status: Published application
- Kind: A1
- Application number: 13/287,425
- Filed: 2011-11-02
- Published: 2012-03-08
- Earliest claimed: 2008-08-08
- Assignees: President and Fellows of Harvard College
- Inventors: George M. Church; François Vigneault; A. Michael Sismour
- Web page: https://patentgrep.com/patent/US20120058521A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12Q 1/6855: Ligating adaptors
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods and compositions for making and using pre-adenylated oligonucleotide sequences are provided.

## Claims

### Claim 1

A method for amplifying a nucleic acid sequence comprising the steps of:
providing preadenylated DNA with the nucleic acid sequence in the presence of RNA ligase and in the absence of ATP whereby the preadenylated DNA binds to the 3′ end of the nucleic acid sequence to form a first ligation product;
providing an oligonucleotide sequence with the first ligation product in the presence of ligase and ATP whereby the oligonucleotide sequence binds to the first ligation product to form a second ligation product; and
amplifying the second ligation product.

### Claim 2 (depends on 1)

The method of claim 1 wherein the RNA ligase is a T4 RNA ligase

### Claim 3 (depends on 1)

The method of claim 1 wherein the preadenylated DNA includes degenerate bases.

### Claim 4 (depends on 2)

The method of claim 2 wherein the preadenylated DNA includes a barcode sequence unique for a particular nucleic acid base or nucleic acid sequence within the preadenylated DNA.

### Claim 5 (depends on 3)

The method of claim 3 wherein the barcode sequence has a length of from 4 to 36 nucleotides.

### Claim 6 (depends on 4)

The method of claim 4 wherein the preadenylated DNA includes a detectable marker.

### Claim 7 (depends on 1)

The method of claim 1 wherein the nucleic acid sequence is DNA or RNA.

### Claim 8 (depends on 7)

The method of claim 7 wherein the DNA is a gene, a gene fragment, an exon, an intron, cDNA, intergenic DNA, recombinant DNA or synthetic DNA.

### Claim 9 (depends on 7)

The method of claim 7 wherein the RNA is messenger RNA, transfer RNA, ribosomal RNA, ribozymes, small interfering RNA, miRNA, or small nucleolar RNA.

### Claim 10 (depends on 1)

The method of claim 1 wherein the amplification is carried out using PCR or polymerase assembly multiplexing.

### Claim 11 (depends on 2)

The method of claim 2 wherein the T4 RNA ligase is T4 RNA ligase 1, T4 RNA ligase 2, truncated T4 RNA ligase 2 or TS2126 RNA ligase 1.

### Claim 12

A method of multiplex amplification of a plurality of miRNA comprising the steps of:
providing a set of preadenylated DNA with the plurality of miRNA in the presence of T4 RNA ligase and in the absence of ATP whereby for each miRNA, the preadenylated DNA binds to the 3′ end of the miRNA to form a first ligation product;
providing an oligonucleotide sequence with the first ligation product in the presence of ligase and ATP whereby the oligonucleotide sequence binds to the first ligation product to form a second ligation product; and
amplifying the second ligation product such that the plurality of miRNA are amplified.

### Claim 13 (depends on 12)

The method of claim 12 wherein the RNA ligase is a T4 RNA ligase

### Claim 14 (depends on 13)

The method of claim 13 wherein the T4 RNA ligase is T4 RNA ligase 1, T4 RNA ligase 2, truncated T4 RNA ligase 2 or TS2126 RNA ligase 1.

### Claim 15 (depends on 12)

The method of claim 12 wherein the preadenylated DNA includes degenerate bases.

### Claim 16 (depends on 12)

The method of claim 12 wherein the preadenylated DNA includes a barcode sequence unique for a particular nucleic acid base or nucleic acid sequence within the preadenylated DNA.

### Claim 17 (depends on 16)

The method of claim 16 wherein the barcode sequence has a length of from 4 to 36 nucleotides.

### Claim 18 (depends on 12)

The method of claim 12 wherein the preadenylated DNA includes a detectable marker.

### Claim 19 (depends on 12)

The method of claim 12 wherein the amplification is carried out using PCR or polymerase assembly multiplexing.
